Skip to search formSkip to main contentSkip to account menu

SYR-472

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

trelagliptin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)